Executive Summary
Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, acute vertigo, meniere's disease, migraine-associated vertigo, benign paroxysmal positional vertigo, vestibular lesions and tinnitus, and ototoxicity. Sensorion offers clinical trial with SENS-111, a treatment against acute vertigo tested on volunteers to determine pharmacokinetics and tolerability; and SENS-401, a class drug to treat sudden sensori neural hearing loss. The company operates through researchers, clinicians and other partners, to develop its drugs. Sensorion is headquartered in Montpellier, France. Sensorion SA (ALSEN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research. Scope - Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios. - Business Description-A brief description of the company's operations. - Key Employees-A list of the key executives of the company. - Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors-A list of the key competitors of the company. - Key Recent Developments-A brief on recent news about the company. Reasons to buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company.
Read More
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
Table of Contents Table of Contents 3 List of Tables 4 List of Figures 4 Sensorion SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Sensorion SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Sensorion SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Sensorion SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 Sensorion SA, Medical Devices Deals, 2012 to YTD 2018 9 Sensorion SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10 Sensorion SA, Pharmaceuticals & Healthcare, Deal Details 11 Venture Financing 11 Sensorion Raises USD4.6 Million in Venture Financing 11 Partnerships 12 Sensorion Enters into Partnership Agreement with Cochlear 12 Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 13 Equity Offering 14 Sensorion Raises USD10.2 Million in Private Placement of Shares 14 Sensorion Raises USD1.8 Million in Private Placement of Shares 16 Sensorion Raises USD8.7 Million in Private Placement of Shares 17 Sensorion Raises USD9 Million in IPO 18 Sensorion SA-Key Competitors 19 Sensorion SA-Key Employees 20 Sensorion SA-Locations And Subsidiaries 21 Head Office 21 Recent Developments 22 Financial Announcements 22 Oct 18, 2018: Sensorion reports pipeline update and first-half-year 2018 results; re-design of SENS-111 study 22 Apr 12, 2018: Sensorion reports full year 2017 results 25 Oct 18, 2017: Sensorion Reports 2017 First-Half Results 27 Mar 14, 2017: Sensorion Reports Full Year 2016 Results in Line with Status of Clinical Development 30 Corporate Communications 32 May 22, 2018: Sensorion Appoints Professor Christine Petit, MD, PhD as Chair of its Scientific Advisory Board 32 Jun 08, 2017: Sensorion Announces Results from 2017 Annual General Meeting 33 Apr 13, 2017: SENSORION: Intensification of the Company's International Development with the Appointment of a New CEO 34 Appendix 35 Methodology 35 About GlobalData 35 Contact Us 35 Disclaimer 35
List of Tables Sensorion SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2 Sensorion SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Sensorion SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Sensorion SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Sensorion SA, Deals By Therapy Area, 2012 to YTD 2018 8 Sensorion SA, Medical Devices Deals, 2012 to YTD 2018 9 Sensorion SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10 Sensorion Raises USD4.6 Million in Venture Financing 11 Sensorion Enters into Partnership Agreement with Cochlear 12 Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 13 Sensorion Raises USD10.2 Million in Private Placement of Shares 14 Sensorion Raises USD1.8 Million in Private Placement of Shares 16 Sensorion Raises USD8.7 Million in Private Placement of Shares 17 Sensorion Raises USD9 Million in IPO 18 Sensorion SA, Key Competitors 19 Sensorion SA, Key Employees 20
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Sensorion SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
|
Agriculture and Animal Care
Automotive, Transportation and Warehousing
Banking Financial Services and Insurance
Consumer Products and Retail
Defense and Security
Education and Recruitment
Energy and Utilities
Food, Beverage and Tobacco
Healthcare
Manufacturing and Construction
Media and Entertainment
Metal, Mining and Chemicals
Public Sector and Administration
Technology and Telecom
